FDA Requests Public Input To Help Redefine ‘Healthy’ Claim On Our Food Labels?

FDA Requests Public Input To Help Redefine ‘Healthy’ Claim On Our Food Labels?

2 Dec 2016

The Federal Food and Drug Administration (“FDA”) regulates food sold in the United States, including all processed foods such as cereals, snacks, and beverages.  The FDA oversees food content and food labeling.

The health food industry has increased dramatically in the past 20 years with growing consumer demand for natural products.  The FDA regulates the term ‘healthy’ and its derivatives.  The term has a specific meaning for particular ingredient types found in food.

Several food manufacturers place the term ‘healthy’ on their products even though the nutrient content claim might not belong there.  Companies have been sued for labeling cereal, cereal bars, and chips as ‘healthy.’  However, sugar content is not currently part of the regulations pertaining to the term ‘healthy.’  Instead,  the current FDA regulations prevent food manufacturers from labeling  a product ‘healthy’ that contains certain amounts of fat, cholesterol or sodium.  The FDA realizes that added sugars and other ingredients and nutrients need to be included within the FDA regulations concerning the implied nutrient content claim ‘healthy.’  As part of the FDA’s ongoing efforts to advise the American public about the food they buy and consume, the FDA has invited the public to comment on the use of the term ‘healthy’ in the labeling of human food products. The comment period began on September 28, 2016 and closes January 26, 2017.  http://www.fda.gov/food/guidanceregulation/guidancedocumentsregulatoryinformation/labelingnutrition/ucm520695.htm.

The public can submit comments electronically through the Federal eRulemaking Portal: http://www.regulations.gov to docket folder FDA-2016-D-2335 or through paper submissions to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852; identify same docket folder.  To date, there are more than 450 comments from consumers, food manufacturers and other organizations.  The FDA has indicated that it is particularly interested in receiving comments about several different topics related to the term ‘healthy,’ including but not limited to:  feedback on how the term is used to be false or misleading; if it should remain as a nutrient content claim; what other criteria should be included in the ‘healthy’ definition, if any; what food types should be permitted to use the term ‘healthy;’ and what other terms might be better to describe foods that promote good eating habits (e.g., ‘nutritious’).  See here for the full list of topics at 21 CFR Part 101, Federal Register / Vol. 81, No. 188 / Wednesday, September 28, 2016 / Proposed Rules – II. Other Issues for Consideration (66564-65).

Share this post on
About Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP focuses on complex civil litigation, including securities, antitrust, wage and hour and consumer class actions as well as shareholder derivative and merger and transactional litigation. The firm is headquartered in New York, and maintains offices in Atlanta, Los Angeles and Philadelphia.

Since its founding in 1995, Faruqi & Faruqi, LLP has served as lead or co-lead counsel in numerous high-profile cases which ultimately provided significant recoveries to investors, direct purchasers, consumers and employees.

To schedule a free consultation with our attorneys and to learn more about your legal rights, call our offices today at (877) 247-4292 or (212) 983-9330.

Tags: Barbara Rohr, case, faruqi & faruqi, faruqi blog, faruqi law, FDA, investigation, litigation, News, settlement notice

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
Send Us a Message
New York
685 Third Avenue 26th Floor
New York New York 10017
(877) 247-4292 / (212) 983-9330
(212) 983-9331
Los Angeles
1901 Avenue of the Stars Suite 1060
Los Angeles California 90067
(424) 256-2884
(424) 256-2885
Atlanta
3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305
(404) 847-0617
(404) 506-9534
Philadelphia
1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103
(215) 277-5770
(215) 277-5771